Replimune

Replimune

  • Founded: 2015
  • Location: Woburn, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin2/Clin3
  • Therapy area: Cutaneous squamous cell carcinoma
  • Drug types: ONC, X_X
  • Lead product: RP1
  • Product link: https://replimune.com/pipeline/
  • Funding: $225M stock Dec 2022; $250M stock Oct 2020; $100M IPO Jul 2018; $55M B Sep 2017; $30M A Sep 2015


replimune.com

linkedin.com

job board


Short description:

Oncolytic immunotherapy

Drug notes:

Also 4 additional trials Clin1/Clin2/Clin3 multiple cancers, organ transplant; RP2 4 trials Clin1/Clin2 multiple cancers; RP3 Clin1 solid tumors

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:

Replimune
Manufacturing Process & Equipment Engineer II
Framingham, MA|7 days ago
Apply
Replimune
Director, Quality Control - Microbiology
Framingham, MA|9 days ago
Replimune
Sr. Vice President, Quality Assurance
Framingham, MA|9 days ago
Replimune
Director, Medical Writing
Woburn, MA|16 days ago
Replimune
Principal Associate II Quality Assurance
Framingham, MA|18 days ago
Replimune
Senior Manufacturing Associate
Framingham, MA|23 days ago


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com